COMPOSITIONS AND METHODS FOR TREATING ATRIAL FIBRILLATION AND/OR ATRIAL FLUTTER IN A HUMAN

摘要

Disclosed are compositions and methods for terminating an episode of atrial fibrillation and/or atrial flutter without also inducing torsades de pointes or ventricular fibrillation in a human patient undergoing an episode of atrial fibrillation and/or atrial flutter. Such methods include orally consuming a single unitary dosage form containing about 50 mg to about 100 mg of vanoxerine, or an equivalent amount of a salt thereof.